JPWO2020123327A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020123327A5 JPWO2020123327A5 JP2021532224A JP2021532224A JPWO2020123327A5 JP WO2020123327 A5 JPWO2020123327 A5 JP WO2020123327A5 JP 2021532224 A JP2021532224 A JP 2021532224A JP 2021532224 A JP2021532224 A JP 2021532224A JP WO2020123327 A5 JPWO2020123327 A5 JP WO2020123327A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- piggybac transposase
- nucleic acid
- piggybac
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108010020764 Transposases Proteins 0.000 claims 31
- 102000008579 Transposases Human genes 0.000 claims 31
- 210000004027 cell Anatomy 0.000 claims 26
- 150000007523 nucleic acids Chemical class 0.000 claims 19
- 108020004707 nucleic acids Proteins 0.000 claims 14
- 102000039446 nucleic acids Human genes 0.000 claims 14
- 238000006467 substitution reaction Methods 0.000 claims 14
- 150000001413 amino acids Chemical group 0.000 claims 12
- 102000004169 proteins and genes Human genes 0.000 claims 11
- 108090000623 proteins and genes Proteins 0.000 claims 11
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims 8
- 229960000310 isoleucine Drugs 0.000 claims 8
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims 8
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical group C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 6
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 claims 6
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 claims 6
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 5
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims 5
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims 5
- 239000004473 Threonine Substances 0.000 claims 5
- 150000002519 isoleucine derivatives Chemical class 0.000 claims 5
- 125000001909 leucine group Chemical group [H]N(*)C(C(*)=O)C([H])([H])C(C([H])([H])[H])C([H])([H])[H] 0.000 claims 4
- 238000000034 method Methods 0.000 claims 4
- 125000000341 threoninyl group Chemical class [H]OC([H])(C([H])([H])[H])C([H])(N([H])[H])C(*)=O 0.000 claims 4
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims 2
- 125000000741 isoleucyl group Chemical group [H]N([H])C(C(C([H])([H])[H])C([H])([H])C([H])([H])[H])C(=O)O* 0.000 claims 2
- 150000002614 leucines Chemical class 0.000 claims 2
- 150000003355 serines Chemical class 0.000 claims 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims 1
- 102000025171 antigen binding proteins Human genes 0.000 claims 1
- 108091000831 antigen binding proteins Proteins 0.000 claims 1
- 210000004978 chinese hamster ovary cell Anatomy 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 210000002865 immune cell Anatomy 0.000 claims 1
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 claims 1
Claims (26)
前記宿主細胞の安定性を高めるようにpiggyBacトランスポザーゼをコードする核酸分子を改変することと;
前記piggyBacトランスポザーゼをコードする改変された核酸分子、並びにpiggyBacトランスポゾンの少なくとも5’及び3’の逆位反復エレメントに隣接する前記目的のタンパク質をコードする核酸配列を含むベクターで前記宿主細胞をコトランスフェクトすることと;
前記細胞を培養して前記目的の組換えタンパク質を発現させることと
を含み、
改変されたpiggyBacトランスポザーゼでトランスフェクトされた前記宿主細胞によって発現される前記目的の組換えタンパク質の力価が、野生型piggyBacトランスポザーゼで、又はpiggyBacトランスポザーゼなしでトランスフェクトされた宿主細胞によって発現される前記目的の組換えタンパク質の力価と比較して改善される、方法。 A method for improving the titer of a recombinant protein of interest expressed by a host cell comprising:
modifying a nucleic acid molecule encoding a piggyBac transposase to increase stability of said host cell;
co-transfecting said host cell with a vector comprising a modified nucleic acid molecule encoding said piggyBac transposase and a nucleic acid sequence encoding said protein of interest flanked by at least the 5′ and 3′ inverted repeat elements of the piggyBac transposon; to do;
culturing said cells to express said recombinant protein of interest;
the titer of said recombinant protein of interest expressed by said host cells transfected with the modified piggyBac transposase expressed by host cells transfected with wild-type piggyBac transposase or without piggyBac transposase; A method wherein the potency of the recombinant protein of interest is improved compared to.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201862777325P | 2018-12-10 | 2018-12-10 | |
US62/777,325 | 2018-12-10 | ||
US201962925516P | 2019-10-24 | 2019-10-24 | |
US62/925,516 | 2019-10-24 | ||
PCT/US2019/065129 WO2020123327A1 (en) | 2018-12-10 | 2019-12-09 | Mutated piggybac transposase |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2022512332A JP2022512332A (en) | 2022-02-03 |
JPWO2020123327A5 true JPWO2020123327A5 (en) | 2022-11-01 |
JP7441840B2 JP7441840B2 (en) | 2024-03-01 |
Family
ID=69143664
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021532224A Active JP7441840B2 (en) | 2018-12-10 | 2019-12-09 | Mutated PIGGYBAC transposase |
Country Status (14)
Country | Link |
---|---|
US (1) | US20220064610A1 (en) |
EP (1) | EP3894549A1 (en) |
JP (1) | JP7441840B2 (en) |
KR (1) | KR20210101270A (en) |
CN (1) | CN113195712A (en) |
AU (1) | AU2019398101A1 (en) |
BR (1) | BR112021011063A2 (en) |
CA (1) | CA3121268A1 (en) |
CL (1) | CL2021001488A1 (en) |
IL (1) | IL283314A (en) |
MX (1) | MX2021006783A (en) |
SG (1) | SG11202106049RA (en) |
TW (1) | TW202035687A (en) |
WO (1) | WO2020123327A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023122716A1 (en) * | 2021-12-22 | 2023-06-29 | Vanderbilt University | Next generation transpososomes |
WO2023212697A1 (en) | 2022-04-28 | 2023-11-02 | Immatics US, Inc. | Membrane-bound il-15, cd8 polypeptides, cells, compositions, and methods of using thereof |
US20230348561A1 (en) | 2022-04-28 | 2023-11-02 | Immatics US, Inc. | Dominant negative tgfbeta receptor polypeptides, cd8 polypeptides, cells, compositions, and methods of using thereof |
US20240066127A1 (en) | 2022-04-28 | 2024-02-29 | Immatics US, Inc. | Il-12 polypeptides, il-15 polypeptides, il-18 polypeptides, cd8 polypeptides, compositions, and methods of using thereof |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4965195A (en) | 1987-10-26 | 1990-10-23 | Immunex Corp. | Interleukin-7 |
US4968607A (en) | 1987-11-25 | 1990-11-06 | Immunex Corporation | Interleukin-1 receptors |
WO1990005183A1 (en) | 1988-10-31 | 1990-05-17 | Immunex Corporation | Interleukin-4 receptors |
WO1991018982A1 (en) | 1990-06-05 | 1991-12-12 | Immunex Corporation | Type ii interleukin-1 receptors |
US6319494B1 (en) | 1990-12-14 | 2001-11-20 | Cell Genesys, Inc. | Chimeric chains for receptor-associated signal transduction pathways |
IL104570A0 (en) | 1992-03-18 | 1993-05-13 | Yeda Res & Dev | Chimeric genes and cells transformed therewith |
US5827642A (en) | 1994-08-31 | 1998-10-27 | Fred Hutchinson Cancer Research Center | Rapid expansion method ("REM") for in vitro propagation of T lymphocytes |
EP0873405B1 (en) | 1996-01-11 | 2004-09-08 | Immunex Corporation | Expression augmenting sequence elements (ease) for eukaryotic expression systems |
CA2196496A1 (en) | 1997-01-31 | 1998-07-31 | Stephen William Watson Michnick | Protein fragment complementation assay for the detection of protein-protein interactions |
US6797514B2 (en) | 2000-02-24 | 2004-09-28 | Xcyte Therapies, Inc. | Simultaneous stimulation and concentration of cells |
US6867041B2 (en) | 2000-02-24 | 2005-03-15 | Xcyte Therapies, Inc. | Simultaneous stimulation and concentration of cells |
KR20030032922A (en) | 2000-02-24 | 2003-04-26 | 싸이트 테라피스 인코포레이티드 | Simultaneous stimulation and concentration of cells |
US7932088B1 (en) * | 2005-04-25 | 2011-04-26 | University Of Notre Dame Du Lac | High efficiency transformation of Plasmodium falciparum by the lepidopteran transposon, piggyBac |
US20110311506A1 (en) | 2009-02-25 | 2011-12-22 | The Johns Hopkins University | Piggybac transposon variants and methods of use |
US8399643B2 (en) | 2009-02-26 | 2013-03-19 | Transposagen Biopharmaceuticals, Inc. | Nucleic acids encoding hyperactive PiggyBac transposases |
US20100311116A1 (en) | 2009-06-04 | 2010-12-09 | Excellgene Sa | Fast generation of high expression stable cell lines expressing recombinant proteins under minimal and short-term selective pressure |
WO2011146862A1 (en) | 2010-05-21 | 2011-11-24 | Bellicum Pharmaceuticals, Inc. | Methods for inducing selective apoptosis |
GB201014169D0 (en) | 2010-08-25 | 2010-10-06 | Cambridge Entpr Ltd | In vitro hepatic differentiation |
PT3214091T (en) | 2010-12-09 | 2019-01-11 | Univ Pennsylvania | Use of chimeric antigen receptor-modified t cells to treat cancer |
BR112013024395B1 (en) | 2011-03-23 | 2021-10-26 | Fred Hutchinson Cancer Research Center | ADOPTIVE COMPOSITIONS OF CELL IMMUNOTHERAPY AND METHOD FOR MANUFACTURING SUCH COMPOSITION |
WO2013012824A2 (en) | 2011-07-15 | 2013-01-24 | The Johns Hopkins University | Trichoplusia ni piggybac transposases with reduced integration activity |
CN103360464A (en) * | 2013-07-17 | 2013-10-23 | 武汉摩尔生物科技有限公司 | Polypeptide, DNA molecule encoding polypeptide, vector, preparation method and application thereof |
US10563225B2 (en) | 2013-07-26 | 2020-02-18 | President And Fellows Of Harvard College | Genome engineering |
DK3129487T3 (en) * | 2014-04-09 | 2020-11-30 | Dna Twopointo Inc | IMPROVED NUCLEIC ACID CONSTRUCTIONS FOR EUKARYOT GENEPRESSION |
EP3018200A1 (en) | 2014-11-07 | 2016-05-11 | Fondazione Matilde Tettamanti e Menotti de Machi Onlus | Improved method for the generation of genetically modified cells |
WO2018098671A1 (en) | 2016-11-30 | 2018-06-07 | China Agricultural University | A method for crispr library screening |
-
2019
- 2019-12-09 BR BR112021011063-1A patent/BR112021011063A2/en unknown
- 2019-12-09 CA CA3121268A patent/CA3121268A1/en active Pending
- 2019-12-09 CN CN201980081292.7A patent/CN113195712A/en active Pending
- 2019-12-09 EP EP19832777.7A patent/EP3894549A1/en active Pending
- 2019-12-09 US US17/299,000 patent/US20220064610A1/en active Pending
- 2019-12-09 SG SG11202106049RA patent/SG11202106049RA/en unknown
- 2019-12-09 AU AU2019398101A patent/AU2019398101A1/en active Pending
- 2019-12-09 WO PCT/US2019/065129 patent/WO2020123327A1/en unknown
- 2019-12-09 KR KR1020217021154A patent/KR20210101270A/en active Search and Examination
- 2019-12-09 MX MX2021006783A patent/MX2021006783A/en unknown
- 2019-12-09 JP JP2021532224A patent/JP7441840B2/en active Active
- 2019-12-10 TW TW108145098A patent/TW202035687A/en unknown
-
2021
- 2021-05-20 IL IL283314A patent/IL283314A/en unknown
- 2021-06-08 CL CL2021001488A patent/CL2021001488A1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2014239686A5 (en) | ||
US20220347289A1 (en) | Nucleotide sequences encoding peptide antigens of sars-cov-2 virus and use thereof | |
JP2017513479A5 (en) | ||
JP2012095652A5 (en) | ||
JP2005120106A5 (en) | ||
RU2013152648A (en) | Adenovirus Monkeys And Hybrid Adenovirus Vectors | |
EA020969B1 (en) | Optimisation of expression of parvoviral rep and cap proteins in insect cells | |
WO2013065772A1 (en) | Method for secreting and producing proteins | |
WO2018030499A1 (en) | Production method for insoluble recombinant protein aggregate | |
JP2009529868A5 (en) | ||
RU2009148322A (en) | NEW LYSOPHOSPHATID ACID ACYLTRANESPHERASES GENES | |
Estes et al. | Uncovering methods for the prevention of protein aggregation and improvement of product quality in a transient expression system | |
JP2005509420A5 (en) | ||
JPWO2020123327A5 (en) | ||
PE20221254A1 (en) | ISOLATED MODIFIED VP1 PROTEIN FROM THE CAPSIDE OF THE ADENO-ASSOCIATED VIRUS SEROTYPE 5 (AAV5), CAPSIDE AND VECTOR BASED ON THE SAME | |
JP2015518728A (en) | Production cell line enhancer | |
RU2020116307A (en) | MODIFIED NOROVIRUS VP1 PROTEINS AND VLP CONTAINING MODIFIED NOROVIRUS VP1 PROTEINS | |
Bae et al. | Hyper-enhanced production of foreign recombinant protein by fusion with the partial polyhedrin of nucleopolyhedrovirus | |
JP2013502217A5 (en) | ||
Chen et al. | Small P particles formed by the Taiwan-native norovirus P domain overexpressed in Komagataella pastoris | |
Zhang et al. | Development of stable HEK293T cell pools expressing CSFV E2 protein: A potential antigen expression platform | |
US20150037866A1 (en) | Composition, Method and Kit for Obtaining Purified Recombinant Proteins | |
RU2546242C1 (en) | RECOMBINANT STRAIN OF YEAST Hansenula polymorpha - PRODUCER OF MAJOR CAPSID PROTEIN L1 OF HUMAN PAPILLOMAVIRUS OF TYPE 18 | |
WO2010079982A3 (en) | Consistent high expression vector containing rep e mutated gene | |
WO2018212467A1 (en) | Fusion protein having c-terminal sequence of lamprey-derived vlrb protein connected to hagfish-derived vlrb protein having hydrophobic tail domain removed therefrom, and use thereof |